SEC Form 4 · accession 0001363213-15-000019
SCICLONE PHARMACEUTICALS INC · SCLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chuncai Meng
Officer — Gen. Counsel & VP Compliance
Period of report
Jun 12, 2015
Accepted (ET)
Jun 15, 2015 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880771
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 12, 2015 | M | 3,007 | $4.52 | A | 3,007 | D | |
| Common Stock | Jun 12, 2015 | S | 3,007 | $9.23 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1,F2 | $4.52 | Jun 12, 2015 | M | 3,007 | D | — | Mar 14, 2024 | Common Stock | 3,007 | 53,333 | D |
Explanation of responses
- F1Granted under the Issuer's 2005 Equity Incentive Plan.
- F225% of such shares vest on February 9, 2015 and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.